The correlation between NAFLD and serum uric acid to serum creatinine ratio

被引:14
作者
Choi, Jangwon [1 ]
Joe, Hyun [1 ]
Oh, Jung-Eun [2 ]
Cho, Yong-Jin [2 ]
Shin, Hwang-Sik [2 ]
Heo, Nam Hun [3 ]
机构
[1] Soonchunhyang Univ, Soonchunhyang Univ Seoul Hosp, Coll Med, Dept Family Med,Coll Med, Seoul, South Korea
[2] Soonchunhyang Univ, Coll Med, Dept Family Med, Cheonan Hosp, Chungnam, South Korea
[3] Soonchunhyang Univ, Coll Med, Biostat Dept Clin Trial Ctr, Cheonan Hosp, Chungnam, South Korea
关键词
NONALCOHOLIC FATTY LIVER; AMERICAN ASSOCIATION; GLOBAL EPIDEMIOLOGY; INSULIN-RESISTANCE; DISEASE; DIAGNOSIS; MANAGEMENT; GENERATION; PREVALENCE; STRESS;
D O I
10.1371/journal.pone.0288666
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundWith the prevalence of non-alcoholic fatty liver disease (NAFLD) increasing worldwide, many noninvasive techniques have been used to improve its diagnosis. Recently, the serum uric acid/creatinine (sUA/sCr) ratio was identified as an indicator of fatty liver disease. Therefore, we examined the relationship between sUA/sCr levels and ultrasound-diagnosed NAFLD in Korean adults. MethodsThis study included 16,666 20-year-olds or older who received health checkups at a university hospital's health promotion center from January to December 2021. Among them, 11,791 non-patients with and without NAFLD were analyzed, excluding those without abdominal ultrasound, those without data on fatty liver, cancer, or chronic kidney disease severity, those with a history of alcohol abuse, and those with serum hs-CRP <5 mg/L. The odds ratio (OR) and 95% confidence interval (CI) of the sUA/sCr ratio according to the presence or absence of fatty liver disease and severity were calculated after correcting for confounding variables using logistic regression analysis. The receiver operating characteristic (ROC) curve and area under the curve (AUC) of the sUA/sCr ratio confirmed and compared the sensitivity and specificity of NAFLD and serum uric acid. ResultssUA/sCr increased with fatty liver severity, and the post-correction OR in the NAFLD group was 1.183 (95% CI: 1.137-1.231) compared to the group without NAFLD. Concerning the fatty liver severity, the post-correction OR in the mild NAFLD group increased to 1.147 (95% CI: 1.099-1.196), and that in the moderate-to-severe NAFLD group increased to 1.275 (95% CI: 1.212-1.341) compared to the group without NAFLD. The sensitivity of sUA/sCr to fatty liver severity was 57.9% for the non-NAFLD group, 56.7% for the mild NAFLD group, and 59.0% for the moderate-to-severe NAFLD group; the specificity of sUA/sCr to fatty liver severity 61.4% for the non-NAFLD group, 57.3% for the mild NAFLD group, and 65.2% for the moderate-to-severe NAFLD group. ConclusionNAFLD severity is associated with sUA/sCR.
引用
收藏
页数:17
相关论文
共 40 条
[1]   Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease [J].
Akhtar, Daud H. ;
Iqbal, Umair ;
Vazquez-Montesino, Luis Miguel ;
Dennis, Brittany B. ;
Ahmed, Aijaz .
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (04) :362-370
[2]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[3]  
[Anonymous], GPAQ AN GUID WHO, V3, P2023
[4]  
Babor TF, 2001, AUDIT ALCOHOL USE DI
[5]   Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options [J].
Bardin, Thomas ;
Richette, Pascal .
BMC MEDICINE, 2017, 15
[6]   Health Care Utilization and Costs by Metabolic Syndrome Risk Factors [J].
Boudreau, D. M. ;
Malone, D. C. ;
Raebel, M. A. ;
Fishman, P. A. ;
Nichols, G. A. ;
Feldstein, A. C. ;
Boscoe, A. N. ;
Ben-Joseph, R. H. ;
Magid, D. J. ;
Okamoto, L. J. .
METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (04) :305-313
[7]   The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Charlton, Michael ;
Cusi, Kenneth ;
Rinella, Mary ;
Harrison, Stephen A. ;
Brunt, Elizabeth M. ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :328-357
[8]   The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
HEPATOLOGY, 2012, 55 (06) :2005-2023
[9]   Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes [J].
Choi, Yea-Jin ;
Shin, Hyun-Soo ;
Choi, Hack Sun ;
Park, Joo-Won ;
Jo, Inho ;
Oh, Eok-Soo ;
Lee, Kang-Yo ;
Lee, Byung-Hoon ;
Johnson, Richard J. ;
Kang, Duk-Hee .
LABORATORY INVESTIGATION, 2014, 94 (10) :1114-1125
[10]  
김기영, 2017, [Health Policy and Mangemnet, 보건행정학회지], V27, P47